Xing Chen is the president and chief investment officer of LICR Fund, Inc., the endowment of Ludwig Institute for Cancer Research. LICR is an international research organization with a singular focus: preventing and controlling cancer. In this interview, he discussed how LICR developed their own institutional competitive edge; how they built one of the best performing hedge fund programs in their industry; and how the investment team is engaged in relentless pursuit of excellence in endowment investing.